SafKan Health Announces FDA 510(k) Clearance for First-of-its-Kind OtoSet™ Ear Cleaning System
Automated Ear Cleaning Device Brings Ear Care Into the 21st Century
Press Release
Shoulder Innovations Announces Equity Financing of $21.6M
HOLLAND, Mich., November 2, 2020 – Shoulder Innovations (SI), an emerging leader in the development of shoulder replacement systems, announced today that it has closed an oversubscribed $21.6 million equity financing.
Shoulder Innovations Announces Equity Financing of $21.6M Read More »
Embody, Inc. Announces FDA 510(k) Clearance of TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair
Holland, Mich. – October 29, 2020 – Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces that one of their portfolio companies, Norfolk, VA based Embody, Inc. has received FDA 510(k) clearance for their TAPESTRY® Biointegrative Implant for Tendon and Ligament Repair.
Virtual Incision Receives Investigational Device Exemption (IDE) to Initiate Study of First-of-its-Kind MIRA Platform
Company Prepares MIRA for Use in Minimally-Invasive Laparoscopic Colon Surgery
HAPPE Spine Announces Additional Technology Patent for Porous and Bioactive PEEK
Holland, Mich., July 08, 2020 — HAPPE Spine announces that it has received notice of allowance from the U.S. Patent and Trademark Office for patent claims providing broad protections for its unique material and manufacturing technology providing fully porous, bioactive polyetheretherketone (PEEK) technology (U.S. Pat. App. No. 14/078,614).
HAPPE Spine Announces Additional Technology Patent for Porous and Bioactive PEEK Read More »
cultivate(MD)™ Seed Fund Announces Participation in Virtual Incision’s $20 Million Financing to Advance First-of-its-Kind Mini-Robot for General Surgery Abdominal Procedures
HOLLAND, Mich., Jan. 13, 2020 PRNewswire — Genesis Innovation Group’s cultivate(MD) Seed Fund, a fund focused on investments into early-stage healthcare companies with innovative technologies, announces its participation in Virtual Incision Corporation’s raise of $20 million in Series B+ financing. Virtual Incision is a medical device company pioneering the first-of-its-kind, miniaturized surgical robot and the